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We examined the influence of diets supplemented with fish and vegetable oils on fatty acid and prostaglandin E2 (PGE2) contents in livers
of non-7,12-dimethylbenz[a]anthracene (DMBA)- and DMBA-treated rats, and in DMBA-induced tumours. Decreased concentrations of
saturated fatty acids and increased unsaturated fatty acid levels were observed in liver phospholipids of rats fed these oils. There was a
marked difference in the concentrations of fatty acids found in the tumours and those present in liver lipids. Oleic acid was the main
unsaturated fatty acid found in the tumour tissue. Both liver and tumour PGE2 contents were clearly correlated to the diet. The PGE2
concentrations were decreased in livers and tumours of rats fed fish (FO) and linseed oils (LO).D 2003 Elsevier Science B.V. All rights reserved.Keywords: Fatty acid; Prostaglandin E2; Carcinogenesis; Fish and vegetable oils; 7,12-Dimethylbenz[a]anthracene1. Introduction
Carcinogenesis is a multistage process which frequently
depends on the environmental agents. It is considered that
35–40% of all human cancers may be associated with the
diet [1,2] and dietary fat is regarded as one of the major risk
factors in cancers of the breast, colon and prostate [3–5].
Epidemiological studies [6,7] and experiments on animals
[8,9] confirm that both amount and type of fat influence
carcinogenesis. It has been reported that fats containing high
concentrations of n 6 polyunsaturated fatty acids (n 6
PUFA), especially linoleic acid (LA; 18:2), promoted the
development of mammary tumours [10–12]. On the other
hand, evening primrose oil (EPO) containing about 75% of
linoleic acid and a relatively high level (9%) of g-linolenic0925-4439/03/$ - see front matter D 2003 Elsevier Science B.V. All rights reserv
doi:10.1016/S0925-4439(03)00020-6
Abbreviations: EPO, evening primrose oil; FO, fish oil; LO, linseed oil;
DMBA, 7,12-dimethylbenz[a]anthracene; PC, phosphatidylcholine; PE,
phosphatidylethanolamine; PUFA, polyunsaturated fatty acid; LA, linoleic
acid; ALA, a-linolenic acid; AA, arachidonic acid; EPA, eicosapentaenoic
acid; DHA, docosahexaenoic acid; GLA, g-linolenic acid
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E-mail address: tokarz@farm.amwaw.edu.pl (A. Tokarz).acid (GLA; 18:3, n 6) was reported to inhibit the develop-
ment of carcinogen-induced rat mammary tumours [13,14].
In contrast to fat containing n 6 PUFAs, fish oils (FO) rich
in n 3 PUFAs, the most abundant being eicosapentaenoic
acid (EPA; 20:5) and docosahexaenoic acid (DHA; 22:6),
were observed to inhibit carcinogen-induced mammary
tumorigenesis in the rat and mouse [9,14–16].
A great number of data indicate a correlation between an
increased PGE2 concentration and the risk of cancer devel-
opment. The PGE2 level observed in the 1970s in tumour
samples gathered from the alimentary tract was higher than
in the adjacent intestinal mucosa [17]. It was noted then that
the PGE2 blood concentration in vessels draining a tumour
area in the alimentary tract was significantly higher than in
arterial blood supplying the tumour, and increased with the
development of the tumour [18].
The content of fatty acids, especially unsaturated fatty
acids in cellular structures, results from their type supplied
with a diet, endogenous synthesis and usage in the body.
Accordingly, in our experiments, we tried to explain in
which way selected edible oils (EPO, FO, and linseed oil,
LO) determine fatty acids composition (wt.%) in phospha-
tidylcholine (PC) and phosphatidylethanolamine (PE)ed.
Table 2
Fatty acid composition in experimental diets (%)
Fatty acids Standard diet SD+EPO SD+FO SD+LO
14:0 1.28 0.60 6.11 0.52
16:0 22.84 14.56 23.86 12.81
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z[a]anthracene (DMBA)-treated rats.
The PGE2 contents in liver and tumour homogenates
were also examined to estimate a correlation between the
risk of tumour development and the PGE2 concentration.
16:1 1.71 0.84 6.94 0.75
18:0 9.79 5.01 6.56 6.33
18:1 n 9 32.98 17.02 21.56 25.42
18:1 n 7 1.73 1.05 2.58 1.08
18:2 n 6 23.14 52.62 11.91 19.20
18:3 n 6 n.d. 5.47 0.44 n.d.
18:3 n 3 6.20 2.55 3.31 33.67
20:1 0.34 0.26 0.33 0.23
20:5 n 3 n.d. n.d. 10.35 n.d.
22:6 n 3 n.d. n.d. 5.44 n.d.
n 3/n 6 0.27 0.044 1.55 1.75
Abbreviations: SD, standard diet; EPO, evening primrose oil; FO, fish oil;
LO, linseed oil; n.d., not detected.2. Materials and methods
2.1. Animals and experiment
Female Sprague–Dawley rats (Maria SklCodowska-
Curie Memorial Cancer Centre and Institute of Oncology)
were used in the study, which was approved by the Ethics
Committee of the Medical University of Warsaw. At the
beginning of the study, the rats (30 days old) were
divided into three groups, which were fed ad libitum
the rat standard diet composed of 19.5% protein, 6.8%
fat, 53.1% carbohydrates, 4.5% fibre and 1.7% minerals.
After 1-week adaptation to the experimental regimen, the
rats were administered by intragastric intubation 0.4 ml of
the following oils daily: EPO (Oeparol, Agropharm,
Poland), FO (Trienyl, Lek Pharmaceutical and Chemistry
Company, Ljubliana, Slovenia), or LO (Gal, Poland). The
test oils were stored in dark bottles in a refrigerator. The
content of fat in each diet was then about 10%, i.e.
equivalent to 24.3% of the caloric value. Fatty acid
compositions of the study oils are presented in Table 1.
However, because the standard diet was a laboratory chow
and oils were administered intragastrically, the type and
amount of fatty acids were sums of their contents in the
chow and in the oil. The daily food intake by adult
animals was about 10 g per rat. The fatty acid daily
intake is shown in Table 2.
When 50 days old, each of dietary groups (EPO, FO, LO)
was subdivided into two groups. One subgroup selected
from each dietary group was administered DMBA (Sigma
Chemical Company, USA) in the amount of 65 mg/kg bodyTable 1
Fatty acid composition in used oils (wt.%)
Fatty acids Standard diet EPO FO LO
14:0 1.28 n.d. n.d. n.d.
16:0 22.84 5.44 24.81 5.06
16:1 1.71 n.d. 12.37 n.d.
18:0 9.79 1.54 4.53 3.73
18:1 n 9 32.98 5.26 12.37 19.68
18:1 n 7 1.73 0.72 3.79 0.68
18:2 n 6 23.14 77.39 12.37 16.21
18:3 n 6 n.d. 9.40 0.82 n.d.
18:3 n 3 6.20 n.d. 1.00 54.52
20:1 0.34 0.25 1.25 0.12
20:5 n 3 n.d. n.d. 23.64 n.d.
22:6 n 3 n.d. n.d. 13.50 n.d.
n 3/n 6 0.27 – 2.89 3.36
Abbreviations: SD, standard diet; EPO, evening primrose oil; FO, fish oil;
LO, linseed oil; n.d., not detected.weight [19]. As a result, six groups were formed; three non-
DMBA-treated groups (EPO, FO, LO) and three DMBA-
treated groups (EPO+DMBA, FO+DMBA, LO+DMBA).
Twenty weeks after DMBA administration, the rats were
decapitated. Livers and tumours were collected and stored
at  70 jC until further analyses.
2.2. Histopathological examination
Tumours, which could be identified with the naked eye,
were collected and their sections were fixed in 10% for-
malin. They were diagnosed by a pathologist as adenocar-
cinomas of the mammary gland. Tumour incidence
(percentage of animals with tumours) was recorded. No
spontaneous tumours were observed in non-DMBA-treated
rats.
2.3. Analysis
Lipids from liver and tumour homogenates were ex-
tracted with chloroform/methanol mixture (2:1; v/v) accord-
ing to the method of Folch et al. [20]. The separation of
lipids and phospholipids into PC and PE was accomplished
by thin-layer chromatography [21]. Fatty acids contained in
PC and PE were estrified with 14% BF3 in methanol
(Sigma) as described by Raclot and Groscolas [22]. Fatty
acids methyl esters were analysed on a gas chromatographTable 3
Mammary tumours in DMBA-treated rats fed diets supplemented with
EPO, FO, and LO
Diet Total number
of rats
Tumour
incidence at
necropsy (%)
Tumour
weight (g),
meanF S.D.
Tumour
weight
ranges (g)
EPO 25 28 5.95F 4.62 0.84–16.44
FO 25 40 1.94F 1.54 0.78–4.23
LO 25 84 1.31F1.28 0.13–3.21
Abbreviations: EPO, evening primrose oil; FO, fish oil; LO, linseed oil.
Table 4
Percentage composition of fatty acids in liver phospholipids of non-DMBA- and DMBA-treated female rats fed the experimental diets (wt.%)
Fatty acids EPO FO LO EPO+DMBA FO+DMBA LO+DMBA
PC
18:0 34.89F 3.83a 28.36F 2.12a 31.77F 2.48 32.64F 2.21 29.19F 1.06 30.25F 2.48
18:1 5.06F 0.72 6.72F 1.02 5.61F1.87 4.69F 1.46 5.38F 0.72 5.96F 1.65
18:2 n 6 7.76F 1.17 9.11F 0.65 8.25F 1.26 7.41F 0.78 8.18F 0.76 9.10F 0.43
20:4 n 6 15.80F 3.15 13.26F 2.25 16.93F 1.78 20.95F 2.59ab 15.53F 1.88a 14.32F 3.62b
20:5 n 3 0.074F 0.03ab 1.14F 0.36a 1.015F 0.28b 0.12F 0.03ab 1.39F 0.40a 1.64F 0.31b
22:6 n 3 5.11F 2.08ab 9.54F 2.16a 8.93F 1.59b 6.31F1.53ab 10.54F 1.46a 9.68F 2.07b
PE
18:0 37.46F 3.46ab 31.11F1.68a 32.91F 2.74b 33.88F 3.30 30.05F 1.32 32.32F 2.58
18:1 3.40F 0.48ab 2.41F 0.24a 2.48F 0.40b 3.08F 0.88 3.34F 0.62 3.30F 1.28
18:2 n 6 3.61F 0.38 3.17F 0.49 3.16F 0.63 3.11F 0.32 3.68F 0.74 4.01F1.40
20:4 n 6 14.64F 3.12a 10.75F 1.34ab 14.45F 0.91b 16.97F 2.47 14.22F 1.55 14.56F 2.32
20:5 n 3 0.12F 0.05ab 1.13F 0.42a 1.27F 0.25b 0.18F 0.03ab 1.54F 0.54a 1.71F 0.55b
22:6 n 3 11.90F 2.86ab 22.47F 4.12a 20.07F 2.50b 13.75F 1.68a 19.27F 2.47ab 14.61F1.15b
Data are expressed as meanF S.D. Values sharing a letter (a, b) are statistically different ( P < 0.05, analysis of variance combined with Tukey–Kramer’s
Multiple Comparison Test). Values from non-DMBA-treated rats were compared with values from other non-DMBA-treated rats, and values from DMBA-
treated rats were compared with values from other DMBA-treated rats.
Abbreviations: EPO, evening primrose oil; FO, fish oil; LO, linseed oil; PC, phosphatidylcholine; PE, phosphatidylethanolamine.
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column, 0.32-mm internal diameter and 0.25-Am stationary
phase HP-225 (50% CNPrPh Me Siloxane). The column
temperature was programmed from 140 to 220 jC. Helium
was used as a carrier gas. Individual fatty acid methyl esters
were identified by comparison with known standards
(Sigma).
The PGE2 was isolated from liver and tumour tissues
using the solid phase extraction (SPE) method and deter-
mined by HPLC [23]. The PGE2 was separated on Lichros-
pher 100RP-18/5 Am column. The mobile phase was a
mixture of acetonitrile and 0.0174 M H3PO4 (328:672, v/
v) and the detection wavelength was 196 nm.Fig. 1. Fatty acid concentrations in PC extracted from tumour tissue. Data are expr
letter (a, b) are statistically different ( P< 0.05, analysis of variance combined with
primrose oil; FO, fish oil; LO, linseed oil; PC, phosphatidylcholine.2.4. Statistical analysis
The results were subjected to an analysis of variance and
a Tukey–Kramer’s Multiple Comparison Test. Values of
P < 0.05 were considered as significant. Data are presented
as meansF S.D.3. Results
A number of tumour-bearing rats in each DMBA-treated
group is shown in Table 3. The highest tumour incidence
(84%) was observed in the LO group (21 of 25 animalsessed as meanF S.D. (n= 7). Values concerning one fatty acid and sharing a
Tukey–Kramer’s Multiple Comparison Test). Abbreviations: EPO, evening
Fig. 2. Fatty acid concentrations in PE extracted from tumour tissue. Data are expressed as meanF S.D. (n= 7). Values concerning one fatty acid and sharing a
letter (a, b) are statistically different ( P < 0.05, analysis of variance combined with Tukey–Kramer’s Multiple Comparison Test). Abbreviations: EPO, evening
primrose oil; FO, fish oil; LO, linseed oil; PE, phosphatidylethanolamine.
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However, although more numerous, the tumours in that
group were smaller in size than in the other groups (Table
3). The tumour incidence in the other groups was as follows:
EPO—28%; FO—40%, which is similar to the soybean oil
group described in our previous study [24].
In our experiment, we analysed 11 fatty acids (myristic
acid, C14:0; palmitic acid, C16:0; palmitooleic acid, C16:1;
stearic acid, C18:0; oleic acid, C18:1 n 9; vaccenic acid,
C18:1 n 7; linoleic acid, LA, C18:2 n 6; a-linolenic
acid, ALA, C 18:3 n 3; arachidonic acid, AA, C 20:4
n 6; eicosapentaenoic acid, EPA, C20:5 n 3; and doco-
sahexaenoic acid, DHA, 22:6 n 3) in livers and tumours.
In the present paper, however, we focus on the essentialFig. 3. PGE2 concentrations in rat livers and tumours. Data are expressed as mean
liver; DMBA-treated rats, liver, tumours) and sharing a letter (a, b, c, d, e, f) are s
Kramer’s Multiple Comparison Test). Abbreviations: EPO, evening primrose oil;PUFAs such as LA, AA, EPA, and DHA as well as on
stearic acid and oleic acid.
There were significant differences in fatty acid concen-
trations among study groups. The lowest AA level was
observed in the PC and PE extracted from livers of the FO
non-DMBA-treated rats and in the PE of DMBA-treated rats
(Table 4). However, statistically significant differences in
AA concentrations appeared in the PC extracted from livers
of DMBA-treated groups. In the EPO group, the AA level
was increased when compared with the FO and LO groups.
In contrast, the FO and the LO groups showed higher
concentrations of liver EPA and DHA than the EPO group.
The EPA level was significantly lower in the FO and LO
groups. Similar statistically significant differences whereF S.D. (n= 7). Values concerning studied tissues (not-DMBA-treated rats,
tatistically different ( P < 0.05, analysis of variance combined with Tukey–
FO, fish oil; LO, linseed oil.
M. Jelin´ska et al. / Biochimica et Biophysica Acta 1637 (2003) 193–199 197found in the DHA level, which was lower in the EPO than
in the FO group (PC and PE of both non-DMBA- and
DMBA-treated rats) and in the LO group (Table 4). The
highest DHA contents were observed in the FO group, and
the highest EPA contents in the LO group. There were not
any statistically significant changes in LA contents. The FO
group showed the lowest, and the EPO group the highest,
level of stearic acid. However, except data concerning the
PC of non-DMBA-treated group, the differences were not
statistically different.
In the phospholipids extracted from tumour tissue, de-
creased levels of stearic acid, AA and DHA were observed
regardless the diet, compared to the liver (Figs. 1 and 2;
Table 4). EPA was not detected at all. On the contrary, the
oleic acid contents were elevated and that acid became the
main unsaturated fatty acid in tumour tissue. The highest
concentrations of LA, AA, and DHAwere noted in the LO,
when compared to the EPO and FO groups.
The prostaglandin E2 (PGE2) concentrations in both liver
and tumour tissues were significantly higher in the EPO
than in the FO and LO groups (Fig. 3) where the levels were
similar. Increased PGE2 levels were also noted in livers of
all DMBA-treated groups compared to the non-DMBA-
treated animals.4. Discussion
In many studies concerning the relationship between
dietary fat and the incidence of breast cancer, fish n 3
PUFAs exert an inhibitory effect against tumorigenesis,
slow primary mammary tumour growth, and decrease meta-
stases in animal models of mammary tumorigenesis [25–
27]. On the contrary, n 6 fatty acids enhance the inci-
dence, growth, and metastases of the tumours [28,29]. In our
study, the lowest tumour incidence was observed in the EPO
group where LA (C 18:2 n 6) was about 77%. However,
EPO also contains about 9% of GLA, which is LA delta-6-
desaturated metabolite. GLA appears to be the most effec-
tive PUFA killing cancer cells followed by AA, EPA, cis
LA, and ALA, whereas DHAwas less effective [30–33]. In
the in vitro studies, GLA stimulated the expression of nm-
23, a metastasis suppressor gene, and as a result inhibited
the invasion of tumour cells [34]. It is also possible that
oenothein B, a strong polyphenolic substance present in the
EPO, is responsible for beneficial activities of this oil [35].
The current study supports the results by Munoz et al. [36]
who reported the absence of mammary tumour promotion in
mice fed diets enriched with n 6 PUFA—LA or GLA
(EPO).
In the FO group, tumour incidence was higher than in the
EPO (40%), despite of high EPA and DHA concentrations
in this diet as well as in the liver lipids. However, the
highest susceptibility to tumorigenesis was observed in the
LO group (84%), although the fatty acid contents in liver
lipids of that group are similar to the FO. LO is the richestsource of ALA. Higher tumour incidence in the FO and LO
groups might be caused by optimal n 3/n 6 ratio dis-
turbances after FO and LO supplementation. The n 3/
n 6 ratios for the diets supplemented with the FO and LO
are 1.5 and 1.75, respectively. These results agree with the
results of Sasaki et al. [37]. They fed the rat 10% fat diets in
which n 3/n 6 ratio were as follows: 0.01, 1.03, 3.96,
and 7.84. The incidence of mammary tumours tended to be
lower in the first (0.01) group than in the other three groups.
What is more, the total number and weight of the mammary
gland tumours in each group increased in a stepwise manner
with the increasing n 3/n 6 ratio and were the highest in
the fourth group (n 3/n 6 = 7.84).
The fatty acid profile and levels of mammary tumour
phospholipids differed from those of healthy liver tissue but
were similar to those observed by other authors in the
prostate [38], spleen, and liver tumour cells [39]. The
highest oleic acid concentrations probably resulted from
its synthesis from stearic acid in the body [40]. One of the
stearic acid sources in the body is dietary glucose. As a
result, a phospholipid structure in tumours make cell mem-
branes less fluid and permeable [41], and more resistant to
the cytotoxic impact of various compounds such as PUFA
peroxides. Cancer cells are characteristically resistant to
lipid peroxidation, in comparison to the normal, healthy
cells [42–44]. This phenomenon is caused by relatively low
PUFA contents in tumours and decreased activities of
cytochrome P-450 and NADPH, whose enzymes participate
in the initiation of lipid peroxidation. Simultaneously, the
antioxidant activity of tumour tissue increases. Cancer cell
membranes are supposed to change cell responses to hor-
mone effects and their susceptibility to the immune system
[43,44]. In our experiment, data regarding the fatty acid
composition of tumours induced in the rats fed the LO
appear to be of interest. PC and PE isolated from tumour
tissue of that group contained the highest levels of LA, AA,
and DHA and identical oleic acid levels (Figs. 1 and 2) in
comparison to the FO and EPO.
Many experiments [13,17,18] show the relationship
between PGE2 content in animal tissues and susceptibility
to tumorigenesis. However, the results are inconsistent.
The analysis of PGE2 concentrations in the current study
shows the absence of correlation between the PGE2 con-
centrations and mammary tumour incidence. The PGE2
contents in livers and tumours of animals fed the diets
supplemented with the EPO, FO, and LO indicate that high
PGE2 (EPO) concentrations may occur together with a low
cancer incidence and conversely the low PGE2 concentra-
tions appear with the high cancer risk (LO). The dietary
fatty acid composition determines the PGE2 synthesis in the
body. The high contribution of n 3 fatty acids (LO, FO)
inhibits the PGE2 synthesis. However, despite the high n 3
fatty acid concentrations in the LO (Table 1) and similar
PGE2 concentrations in the FO and LO groups, the tumour
incidence is higher by 50% in the LO than in the FO group.
The present study agrees with the results of Sasaki et al.
M. Jelin´ska et al. / Biochimica et Biophysica Acta 1637 (2003) 193–199198[37]. This finding suggests that the PGE2 may be one of the
agents affecting carcinogenesis, but it is not of the crucial
importance.
Our findings confirm the importance of the appropriate
type and amount of fatty acids in the diet. They also show
how complex and difficult to prevent tumorigenesis is. It
may be concluded that fatty acids participating in various
pathological processes act at the molecular level and, having
various chemical structures, cause numerous pharmacolog-
ical effects.5. Conclusions
1. Tumour incidence was strictly correlated to the type of
the fat fed.
2. The process of tumorigenesis is positively correlated to
the higher n 3/n 6 ratios.
3. The presence of GLA and polyphenolic antioxidant was
probably the reason of the lowest tumour incidence in the
EPO group, despite of a high LA level in that oil.
4. Tumour incidence was negatively correlated to PGE2
synthesis in livers and tumours. That indicates PGE2 is
probably not a decisive factor in tumorigenesis, although
it participates in the process.
5. Oleic acid is the main unsaturated fatty acid in rat tumour
tissue, which may determine physicochemical properties
of tumour cell membranes.Acknowledgements
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